Quantum BioPharma Overview
Quantum BioPharma (QNTM) has a PEG ratio of 0.79, below the sector sector average of 10.05.
Get informed when a big investor buys or sells
+ Follow0.79
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for QNTM is 0.79. That is below the sector sector average of 10.05. Investors often review this figure alongside Quantum BioPharma's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, QNTM currently prints 0.79 for PEG ratio, while the sector average sits near 10.05. That is roughly 92.1% below the sector mean. Large gaps often invite a closer look at Quantum BioPharma's growth, margins, and balance sheet.
A PEG ratio of 0.79 for Quantum BioPharma is not 'good' or 'bad' on its own. Compare it with the peer average (10.05) and with QNTM's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting QNTM's PEG ratio (0.79), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
